Company / EPS (Diluted)
DBV Technologies S.A. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.17
FY2025
5-year range
-$2.95 / -$0.76
FY2021-FY2025
Trend
-53.9%
vs FY2024
Sector context
#92 of 204
Health Care
What the data says
At $-1.17, DBV Technologies S.A.'s eps (diluted) ranks #92 of 204 in the Health Care sector. Improved from $-1.24 to $-1.17 over the past 2 years.
Based on SEC 10-K filings.
-1.17 in FY2025.
Improved from $-1.24 to $-1.17 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 204 in Health CareTop 45% of 204This company -$1.17 Sector average -$1.03
▼
-13.4% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 53.9% year-over-year.
- Ranks #92 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.17 | -53.9% |
| FY2024 | -$0.76 | +38.7% |
| FY2023 | -$1.24 | +30.3% |
| FY2022 | -$1.78 | +39.7% |
| FY2021 | -$2.95 | +36.6% |
| FY2020 | -$4.65 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026